Comparison of percutaneous cross screw fixation versus open reduction and internal fixation for pelvic Day type II crescent fracture-dislocation: Case-control study
Objective: To investigate the clinical outcomes of percutaneous cross screws internal fixation for pelvic Day type II crescent fracture-dislocation.
Methods: We reviewed 66 consecutive patients undergoing surgical treatment for Day type II crescent fracture-dislocation from June 2005 to December 2017. Percutaneous cross screws internal fixation was performed in 40 patients, and open reduction and internal fixation was performed in 26 patients. The patient characteristics, surgical complications, radiographic and clinical outcomes and were compared.
Results: There was no statistically difference on the mean time from injury to surgery between the two groups. The time of operation, the amount of blood loss, the length of incision and the hospital stay were significantly shorter in the percutaneous cross screws internal fixation Group. No significant difference on Matta scores and Majeed scores between the two groups. The open reduction and internal fixation Group resulted in a higher rate of intraoperative hemorrhage, nerve injury, discomfort and pain.
Conclusion: Percutaneous cross screws internal fixation for Day Ⅱ type pelvic crescent fracture-dislocation was safe and effective. Minimally invasive fixation had the advantages of short operation and hospitalization time, less intraoperative bleeding and surgical trauma.
Figure 1
Figure 2
Posted 30 Dec, 2020
On 09 Jan, 2021
On 28 Dec, 2020
Invitations sent on 20 Dec, 2020
On 14 Dec, 2020
On 14 Dec, 2020
On 14 Dec, 2020
On 30 Nov, 2020
Received 21 Sep, 2020
Received 20 Sep, 2020
On 08 Sep, 2020
On 14 Jul, 2020
Invitations sent on 04 Jun, 2020
On 03 Jun, 2020
On 02 Jun, 2020
On 02 Jun, 2020
On 02 Jun, 2020
On 02 Jun, 2020
On 01 Jun, 2020
On 16 May, 2020
On 12 May, 2020
Comparison of percutaneous cross screw fixation versus open reduction and internal fixation for pelvic Day type II crescent fracture-dislocation: Case-control study
Posted 30 Dec, 2020
On 09 Jan, 2021
On 28 Dec, 2020
Invitations sent on 20 Dec, 2020
On 14 Dec, 2020
On 14 Dec, 2020
On 14 Dec, 2020
On 30 Nov, 2020
Received 21 Sep, 2020
Received 20 Sep, 2020
On 08 Sep, 2020
On 14 Jul, 2020
Invitations sent on 04 Jun, 2020
On 03 Jun, 2020
On 02 Jun, 2020
On 02 Jun, 2020
On 02 Jun, 2020
On 02 Jun, 2020
On 01 Jun, 2020
On 16 May, 2020
On 12 May, 2020
Objective: To investigate the clinical outcomes of percutaneous cross screws internal fixation for pelvic Day type II crescent fracture-dislocation.
Methods: We reviewed 66 consecutive patients undergoing surgical treatment for Day type II crescent fracture-dislocation from June 2005 to December 2017. Percutaneous cross screws internal fixation was performed in 40 patients, and open reduction and internal fixation was performed in 26 patients. The patient characteristics, surgical complications, radiographic and clinical outcomes and were compared.
Results: There was no statistically difference on the mean time from injury to surgery between the two groups. The time of operation, the amount of blood loss, the length of incision and the hospital stay were significantly shorter in the percutaneous cross screws internal fixation Group. No significant difference on Matta scores and Majeed scores between the two groups. The open reduction and internal fixation Group resulted in a higher rate of intraoperative hemorrhage, nerve injury, discomfort and pain.
Conclusion: Percutaneous cross screws internal fixation for Day Ⅱ type pelvic crescent fracture-dislocation was safe and effective. Minimally invasive fixation had the advantages of short operation and hospitalization time, less intraoperative bleeding and surgical trauma.
Figure 1
Figure 2